These results suggest that YNJ can alleviate LPS-induced ALI symptoms by inhibiting alveolar epithelial pyroptosis via the NF-κB/NLRP3 pathway (Figure 9). The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.